GRLS icon

GRLS

Lightning icon

8.9737 EUR

-0.71%

Today

+1.17%

1D

Market is closed

Sun

Closed

Mon

10:01 AM ~ 6:30 PM

Tue

10:01 AM ~ 6:30 PM

Wed

10:01 AM ~ 6:30 PM

Thu

10:01 AM ~ 6:30 PM

Fri

10:01 AM ~ 6:30 PM

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

Grifols Leveraged ( Spain )

Currency

EUR

Standard Leverage

1X

Lightning Icon

Enhanced Leverage

3X

Lightning Icon

Overnight Fees Buy

-0.0137%

Overnight Fees Sell

-0.0030%

Market Cap

6.08B

Avg Daily Volume

2.95M

52 Week High

13.7 EUR

52 Week Low

7.978 EUR

Trading Hours

See hours

Overnight Fees Calculator

ExposureUnits
USD
Daily Overnight Fee %Daily Overnight Fee $
BUYS-0.01370%$(0.137)
SELLS-0.00300%$(0.030)

*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.

Business Summary

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Top News

Grifols

+1.17%

CORRECTED-Grifols says on course to meet 2025 outlook as net profit triples

reuters.com

11mo ago

No Image

Frequently Asked Questions

What defines retail stocks?

Retail stocks represent businesses that sell goods directly to consumers, including brick-and-mortar stores, e-commerce platforms, and consumer brands.


Are retail stocks seasonal?

Yes. Sales tend to spike during holidays and promotional periods like Black Friday, which can significantly impact quarterly earnings.


What factors influence retail stock performance?

Consumer confidence, inflation, disposable income, and trends in online shopping all play major roles in retail stock movements.


Is the retail sector considered risky?

It can be, due to changing consumer behavior, competition from e-commerce, and sensitivity to economic conditions like interest rates and employment levels.